In a report on present market situations – and the strategic view going ahead – JPMorgan’s Marko Kolanovic sees loads of causes for optimism. Kolanovic sees that threat has eased in the previous couple of weeks, and taking the standard every day fluctuations into consideration, markets are more likely to see a sustained rally.The most important information, in Kolanovic’s view, are the constructive reviews concerning the fast improvement and imminent availability of a COVID-19 vaccine. This can be a ‘game-changer,’ permitting buyers to “look by the latest surge in COVID-19 instances to the approaching finish of the pandemic and broader reopening of the economic system.”In an in depth second, so far as market significance is worried, is the break up results of the nationwide election. Kolanovic describes a Biden Presidency mixed with elevated Republican power within the Home and a continued Republican Senate majority as ‘the most effective of each worlds.’ A divided authorities is unlikely to dismantle the pro-business strikes taken by the Trump Administration, whereas Biden is more likely to ease the commerce warfare. The consequence, in keeping with the Kolanovic staff, will probably be “much less market volatility, which may drive inflows to threat belongings.”To this finish, JPM’s inventory analysts have been busy scanning the tickers, looking for out these which are more likely to win – or lose – within the coming months. Of explicit curiosity, we’ve pulled the TipRanks knowledge on two shares that the agency predicts will present double-digit progress, and one which JPM says to keep away from. Vroom, Inc. (VRM)We’ll begin with Vroom, an internet retailer within the used automobile area. Along with vehicles, the corporate additionally sells spare elements and equipment, and affords insurance coverage, automobile leases, and funding for purchases, for US clients solely.Vroom is a newcomer within the markets; it IPO’d in June and rose shortly, peaking in on September 1. Since then, the shares have slipped and at the moment are down 22% since their first day’s shut. The rise and fall are the results of conflicting tailwinds and headwinds pushing towards the inventory.On the constructive aspect, Vroom has gained throughout the basic shift to on-line retail. Additionally, the corporate’s concentrate on used autos was useful throughout the pandemic, when clients have been nervous or cash-strapped – however in both case, reluctant to put out massive sums for a brand new automobile. On the unfavorable aspect of the ledger, that reluctance to spend slipped over to the used automobile market, too. Vroom needed to cope with low margins whereas reducing costs to draw gross sales.Protecting the inventory for JPM, analyst Rajat Gupta sees the inventory’s present state as a possibility for buyers. The unhealthy occasions are possible short-term, he believes, and this firm is about to take off. “Web-net, with near-term expectations now reset and potential for acceleration in each unit progress and gross revenue into 2021, we view the setup as favorable within the close to to medium time period for the inventory with little incremental unfavorable catalysts… we consider execution will probably be key given heavy reliance on third events for key operational points corresponding to reconditioning and logistics,” Gupta wrote.In keeping with this evaluation, Gupta charges the inventory an Obese (i.e. Purchase), and his $70 worth goal implies an upside of 91% for the yr forward. (To look at Gupta’s observe file, click on right here)Even after the autumn in its share worth, Vroom retains a Sturdy Purchase from the analyst consensus. The score relies on 11 opinions, together with 10 Buys and 1 Promote. VRM is promoting for $36.81, and its $59.40 common worth goal suggests it has room for ~61% progress on the one-year horizon. (See VRM inventory evaluation on TipRanks)Colfax Company (CFX)Subsequent up is Colfax, a distinct segment manufacturing firm. Colfax produces a variety of apparatus for the welding, medical gadget, and air and fuel dealing with markets, starting from medical tools for joint reconstruction to welding helmets and reducing torches. Whereas it could sound incongruous, the mix works for Colfax, and the corporate is experiencing a turnaround from corona disaster losses in 2Q20.The third quarter earnings, at 41 cents per share, confirmed each good and unhealthy. It was down 32% yr over yr, however has greater than quadrupled sequentially and beat the estimates. Revenues have been up 29% sequentially, coming in at $805 million. Administration expects to see continued sequential enhancements by the rest of 2020, and predicts full-year earnings within the vary of 45 cents to 50 cents per share.Representing JPM, 5-star analyst Stephen Tusa commented, “[We] see the inventory as being comparatively low-cost in comparison with shut friends throughout the Fab Tech and Med Tech area with vital upside publish COVID-19 that doesn’t seem like solely realized within the valuation as of but in comparison with the peer FY2 expectations. CFX has robust manufacturers and franchises… and an underappreciated productiveness alternative with major finish market bounce again in Fab Tech and demand spikes in Med Tech.”Tusa backs his upbeat feedback with an Obese (i.e. Purchase) score and a $52 worth goal indicating his confidence in a 38% one-year upside. (To look at Tusa’s observe file, click on right here)Total, Colfax has a Reasonable Purchase score from the analyst consensus, based mostly on 8 opinions breaking down to five Buys, 2 Holds, and 1 Promote. Nonetheless, the bulk count on shares to remain vary sure for now, as the present $38.63 common worth goal signifies. (See CFX inventory evaluation on TipRanks)Past Meat (BYND)Final on at present’s listing of JPM calls is Past Meat, an organization that made quite a lot of waves final yr when it raised over $3.8 billion in its IPO. The corporate affords a vegetarian-based meat substitute, and it markets as extra nutritious, higher tasting – and extra like meat – than competing merchandise. The corporate was based again in 2009, and has expanded its lineup of merchandise to incorporate simulated beef, pork, and rooster merchandise.Total, BYND inventory nonetheless presents a constructive façade. The shares are up 88% year-to-date, and the corporate registered a internet revenue in 1Q20, simply because the corona disaster began. Since then, nonetheless, earnings have turned unfavorable – and even worse, revenues confirmed a powerful sequential drop in Q3. The most recent quarterly figures confirmed $94 million on the high line, down 16% from Q2 and properly beneath the forecast of $133 million, and an EPS lack of 28 cents – far worse than the 3-cent loss predicted. The most important hit to Past Meat got here from declines in restaurant enterprise that was solely partially redeemed by a 40% surge in grocery gross sales. The corporate did announce a partnership with McDonald’s to supply the meat substitute for the quick meals big’s new McPlant menu, however even that announcement was bungled. BYND shares fell sharply when it was rumored that McD’s had developed the meat substitute in-house. Whereas that false impression has been corrected, BYND has solely partially bounced again.Briefly, this firm is dealing with critical headwinds within the near-term, and JPM is advising warning resulting from “visibility so low and the latest quarter surprisingly mushy.” Ken Goldman, rated 5-stars at TipRanks, writes of BYND, “We at the moment are making an attempt to mannequin an organization for which (a) we aren’t precisely clear why 3Q was so unhealthy (the corporate’s clarification didn’t appear to be backed up by significant knowledge), and (b) the partnership with McDonald’s may both be a game-changer or a dud.”Goldman’s warning is obvious from his Underweight score (i.e. a Promote), and his $104 worth goal suggests a 26% draw back to the inventory. (To look at Goldman’s observe file, click on right here)JPM isn’t the one agency advising warning right here. Past Meat’s analyst consensus score is a Reasonable Promote, based mostly on 2 Buys, 7 Holds, and seven Sells set in latest weeks. The inventory is promoting for $141.91 and its common worth goal of $110.71 signifies a possible draw back of twenty-two% within the coming yr. (See BYND inventory evaluation on TipRanks)To search out good concepts for shares buying and selling at engaging valuations, go to TipRanks’ Finest Shares to Purchase, a newly launched software that unites all of TipRanks’ fairness insights.Disclaimer: The opinions expressed on this article are solely these of the featured analysts. The content material is meant for use for informational functions solely. It is extremely vital to do your personal evaluation earlier than making any funding.